Investor appetite for extreme mortality exposure is about to be tested with a new offering of notes under Swiss Re's long-standing Vita series of transactions, Trading Risk understands.
Investor appetite for extreme mortality exposure is about to be tested with a new offering of notes under Swiss Re's long-standing Vita series of transactions, Trading Risk understands.